The world's first oral GLP-1RA Novoxin (semaglutide tablets) is fully launched in China

2025-01-11 18:48:09

Novo Nordisk announced that the world's first oral glucagon-like peptide-1 receptor agonist (GLP-1RA) - Novoxin (semaglutide tablets) has been fully launched in China. With its convenient oral administration method, Novoxin helps patients benefit from GLP-1RA drugs earlier, helps achieve high-quality blood sugar targets and comprehensive metabolic management, and brings an innovative category to the clinical treatment of type 2 diabetes in China.

Novo Nordisk

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    South Korean Ministry of Foreign Affairs: U.S. Secretary of State Rubio and South Korean and Japanese diplomats agreed to strengthen cooperation in areas such as energy, shipbuilding, and supply chain security (including critical minerals and artificial intelligence).
                            2025-07-11

                                    CoreWeave becomes the first hyperscale cloud service provider to deploy NVIDIA's GB300 NVL72 platform.
                            2025-07-04

                                    TSMC (TSM.N) responded to the Wall Street Journal report by saying its investment in the United States will not affect its existing investment plans in other regions.
                            2025-07-04

                                    Market news: Apple (AAPL.O) plans to launch new MacBook Pro, iPhone 17E and iPad in early 2026.
                            2025-07-11

                                    Shanghai: The scale of the city's artificial intelligence industry exceeded 118 billion yuan in the first quarter of this year
                            2025-07-10